Molecular diagnosis of tuberous sclerosis is established through the identification of a pathogenic variant of TSC1 or TSC2, regardless of the clinical findings (Krueger et al., 2013; Northrup et al., 2021). The gene discussed is TSC2; the disease is tuberous sclerosis.